These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1352597)

  • 1. Debrisoquine 4-hydroxylase (CYP2D) locus and possible susceptibility to schizophrenia.
    Vallada H; Collier D; Dawson E; Owen M; Nanko S; Murray R; Gill M
    Lancet; 1992 Jul; 340(8812):181-2. PubMed ID: 1352597
    [No Abstract]   [Full Text] [Related]  

  • 2. Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus.
    Polymeropoulos MH; Rath DS; Xiao H; Merril CR
    Nucleic Acids Res; 1991 Apr; 19(8):1961. PubMed ID: 2030982
    [No Abstract]   [Full Text] [Related]  

  • 3. Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.
    Trofatter JA; Gusella JF; Haines JL
    Nucleic Acids Res; 1991 May; 19(10):2802. PubMed ID: 2041763
    [No Abstract]   [Full Text] [Related]  

  • 4. An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.
    Dawson E; Powell JF; Nöthen MM; Crocq MA; Lanczik M; Körner J; Rietschel M; van Os J; Wright P; Gill M
    Psychiatr Genet; 1994; 4(4):215-8. PubMed ID: 7712118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility.
    Buchert ET; Woosley RL; Swain SM; Oliver SJ; Coughlin SS; Pickle L; Trock B; Riegel AT
    Pharmacogenetics; 1993 Dec; 3(6):322-7. PubMed ID: 8148873
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of genetic differences in debrisoquine hydroxylase activity.
    Wolf CR; Spurr NK
    Hepatology; 1992 Feb; 15(2):360. PubMed ID: 1735543
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the primary gene defect at the cytochrome P450 CYP2D locus.
    Gough AC; Miles JS; Spurr NK; Moss JE; Gaedigk A; Eichelbaum M; Wolf CR
    Nature; 1990 Oct; 347(6295):773-6. PubMed ID: 1978251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).
    Daniels J; Williams J; Asherson P; McGuffin P; Owen M
    Am J Med Genet; 1995 Feb; 60(1):85-7. PubMed ID: 7485241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.
    Gonzalez FJ; Vilbois F; Hardwick JP; McBride OW; Nebert DW; Gelboin HV; Meyer UA
    Genomics; 1988 Feb; 2(2):174-9. PubMed ID: 3410476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack association between schizophrenia and the CYP2D6 gene polymorphisms.
    Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK
    Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057
    [No Abstract]   [Full Text] [Related]  

  • 11. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
    Kimura S; Umeno M; Skoda RC; Meyer UA; Gonzalez FJ
    Am J Hum Genet; 1989 Dec; 45(6):889-904. PubMed ID: 2574001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
    Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC
    Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus.
    Mura C; Broyart JP; Jacqz E; Elion J; Krishnamoorthy R
    Nucleic Acids Res; 1991 Mar; 19(5):1162. PubMed ID: 1673559
    [No Abstract]   [Full Text] [Related]  

  • 14. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacqz-Aigrain E; Krishnamoorthy R
    Hum Genet; 1994 Oct; 94(4):401-6. PubMed ID: 7927337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk.
    Nebert DW
    Cancer Cells; 1991 Mar; 3(3):93-6. PubMed ID: 2054261
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.
    Romkes-Sparks M; Mnuskin A; Chern HD; Persad R; Fleming C; Sibley GN; Smith P; Wilkinson GR; Branch RA
    Carcinogenesis; 1994 Sep; 15(9):1955-61. PubMed ID: 7923590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of debrisoquine phenotype.
    Wolf CR; Moss JE; Miles JS; Gough AC; Spurr NK
    Lancet; 1991 Mar; 337(8741):623. PubMed ID: 1671985
    [No Abstract]   [Full Text] [Related]  

  • 19. Debrisoquine hydroxylase and Parkinson's disease.
    Kondo I; Kanazawa I
    Adv Neurol; 1993; 60():338-42. PubMed ID: 8420147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
    Aklillu E; Persson I; Bertilsson L; Johansson I; Rodrigues F; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 1996 Jul; 278(1):441-6. PubMed ID: 8764380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.